FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA | MGI Pharma | SuperGen | Dacogen

SPOTLIGHT: Developers pull European Dacogen application

Tools

MGI Pharma and SuperGen have pulled their European application for Dacogen injection saying they will need to provide more clinical data. But the companies added that the decision won't have an impact on their US application and have submitted their response to the FDA's approvable letter. Release


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about FDA   MGI Pharma   SuperGen   Dacogen